Zobrazeno 1 - 10
of 129
pro vyhledávání: '"Yoshikuni Inokawa"'
Autor:
Takahiro Shinozuka, Mitsuro Kanda, Yusuke Sato, Dai Shimizu, Chie Tanaka, Shinichi Umeda, Yoshikuni Inokawa, Norifumi Hattori, Masamichi Hayashi, Goro Nakayama, Yasuhiro Kodera
Publikováno v:
Cancer Medicine, Vol 12, Iss 24, Pp 22185-22195 (2023)
Abstract Background Some conventional prognostic biomarkers for esophageal squamous cell carcinoma (ESCC) have the disadvantage that they have only been investigated at the level of either mRNA or protein levels or only in individual cohorts. Associa
Externí odkaz:
https://doaj.org/article/dabb316ce084404cb45c693c4db9040a
Autor:
Takahiro Shinozuka, Mitsuro Kanda, Dai Shimizu, Shinichi Umeda, Hideki Takami, Yoshikuni Inokawa, Norifumi Hattori, Masamichi Hayashi, Chie Tanaka, Goro Nakayama, Yasuhiro Kodera
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract There is a need for serum diagnostic biomarkers to improve the prognosis of solid malignant tumors. Here, we conducted a single-institutional study to evaluate the diagnostic performance of serum stromal cell-derived factor 4 (SDF4) levels i
Externí odkaz:
https://doaj.org/article/0f4062e84cd94595b272a1235fd9cdf3
Autor:
Yoshikuni Inokawa, Masamichi Hayashi, Shahnaz Begum, Maartje G. Noordhuis, Daivd Sidransky, Joseph Califano, Wayne Koch, Mariana Brait, William H. Westra, Mohammad O. Hoque
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background HPV-positive oropharyngeal squamous cell carcinomas (OPSCCs) are sensitive to chemo-radiation therapy and have favorable survival outcomes compared with HPV-negative cancers. These tumors are usually not related to tobacco and alc
Externí odkaz:
https://doaj.org/article/51d677fd606a4d56ae1d84b4059ade0d
Autor:
Yuki Sunagawa, Suguru Yamada, Fuminori Sonohara, Keisuke Kurimoto, Nobutake Tanaka, Yunosuke Suzuki, Yoshikuni Inokawa, Hideki Takami, Masamichi Hayashi, Mitsuro Kanda, Chie Tanaka, Goro Nakayama, Masahiko Koike, Yasuhiro Kodera
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Circular RNA (circRNA) is a type of non-coding RNA known to affect cancer-related micro RNAs and various transcription factors. circRNA has promise as a cancer-related biomarker because its circular structure affords high stability. We found
Externí odkaz:
https://doaj.org/article/f10be62b19494c76af33c843a3615951
Autor:
Mitsuro Kanda, Dai Shimizu, Kazushi Miyata, Osamu Maeda, Chie Tanaka, Yoshikuni Inokawa, Norofumi Hattori, Masamichi Hayashi, Masahiko Ando, Yachiyo Kuwatsuka, Kenta Murotani, Goro Nakayama, Masahiko Koike, Yuichi Ando, Tomoki Ebata, Yasuhiro Kodera
Publikováno v:
Contemporary Clinical Trials Communications, Vol 24, Iss , Pp 100853- (2021)
In Japan, esophagectomy after two courses of 5-fluorouracil plus cisplatin is regarded a standard strategy for treating resectable stage II or III esophageal squamous cell carcinoma (ESCC). However, 5-fluorouracil plus cisplatin does not benefit coho
Externí odkaz:
https://doaj.org/article/60bd584ed5604ef4b37d38428dccd043
Autor:
Masamichi Hayashi, Daigo Kobayashi, Hideki Takami, Yoshikuni Inokawa, Nobutake Tanaka, Keisuke Kurimoto, Koki Nakanishi, Shinichi Umeda, Dai Shimizu, Norifumi Hattori, Mitsuro Kanda, Chie Tanaka, Goro Nakayama, Yasuhiro Kodera
Publikováno v:
Nutrition and Cancer. 75:1330-1339
Autor:
Ikue, Nonogaki, Mitsuro, Kanda, Dai, Shimizu, Yoshikuni, Inokawa, Norifumi, Hattori, Masamichi, Hayashi, Chie, Tanaka, Masahiko, Koike, Goro, Nakayama, Yasuhiro, Kodera
Publikováno v:
World Journal of Surgery. 47:217-226
Usefulness of various nutritional indices for management of patients with esophageal squamous cell carcinoma (ESCC) has been reported. Although Controlling Nutritional Status (CONUT) score is among promising indices to predict outcome, the optimal ti
Autor:
Koichi, Sawaki, Mitsuro, Kanda, Hayato, Baba, Yoshikuni, Inokawa, Norifumi, Hattori, Masamichi, Hayashi, Chie, Tanaka, Yasuhiro, Kodera
Publikováno v:
Annals of Surgical Oncology. 30:628-636
Novel therapeutic targets are needed to improve the poor prognosis of patients with advanced gastric cancer. The aim of this study was to identify a novel therapeutic target for the treatment of GC and to investigate the potential therapeutic value o
Autor:
TAKAYOSHI KISHIDA, MITSURO KANDA, YUSUKE SATO, DAI SHIMIZU, YOSHIKUNI INOKAWA, NORIFUMI HATTORI, MASAMICHI HAYASHI, CHIE TANAKA, GORO NAKAYAMA, YASUHIRO KODERA
Publikováno v:
Cancer Genomics & Proteomics (1109-6535); Nov/Dec2023, Vol. 20 Issue 6, p617-625, 9p
Autor:
Tomohisa, Otsu, Yoshikuni, Inokawa, Hideki, Takami, Masamichi, Hayashi, Keisuke, Kurimoto, Nobutake, Tanaka, Haruyoshi, Tanaka, Dai, Shimizu, Norifumi, Hattori, Mitsuro, Kanda, Chie, Tanaka, Goro, Nakayama, Yasuhiro, Kodera
Publikováno v:
Anticancer Research. 42:3889-3894
The regimen of nanoliposomal irinotecan plus 5-fluorouracil and leucovorin (Nal-IRI/FL) was approved in Japan as second-line chemotherapy after gemcitabine-based treatment for pancreatic ductal adenocarcinoma (PDAC) in 2020. We examined the differenc